Search Results - "Burrell, Louise M."

Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.

Authors: Burrell, Louise M. Gayed, Daniel Griggs, Karen et al.

Source: PLoS ONE. 2/13/2017, Vol. 12 Issue 2, p1-12. 12p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The Need for Individualized Risk Assessment in Cardiovascular Disease.

Authors: Lim, Hui Yin Burrell, Louise M. Brook, Rowena et al.

Source: Journal of Personalized Medicine. Jul2022, Vol. 12 Issue 7, p1140-1140. 15p.

Cardiorenal Protective Effects of Vasopeptidase Inhibition with Omapatrilat in Hypertensive Transgenic (mREN-2)27 Rats.

Authors: Mifsud, Sally A. Burrell, Louise M. Kubota, Eiji et al.

Source: Clinical & Experimental Hypertension. Jan2004, Vol. 26 Issue 1, p69-80. 12p.

Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.

Authors: Narendren, Ahthavan Whitehead, Natalie Burrell, Louise M. et al.

Source: Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 15, p4416. 26p.

Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in?

Authors: Patel, Sheila K Velkoska, Elena Burrell, Louise M

Source: Clinical & Experimental Pharmacology & Physiology. Aug2013, Vol. 40 Issue 8, p551-559.

VASOPRESSIN V[sub1A] RECEPTOR ANTAGONISM DOES NOT REVERSE ADRENOCORTICOTROPHIN-INDUCED HYPERTENSION IN THE RAT.

Authors: Fraser, Taffine B. Turner, Steven W. Cheng Wen et al.

Source: Clinical & Experimental Pharmacology & Physiology. Nov2000, Vol. 27 Issue 11, p866.

Circulating ACE2: a novel biomarker of cardiovascular risk.

Authors: Ramchand, Jay Burrell, Louise M

Source: Lancet. 10/3/2020, Vol. 396 Issue 10256, p937-939. 3p.

Author reply.

Authors: Neef, Pieter A. Burrell, Louise M. McDonald, Christine F. et al.

Source: Internal Medicine Journal. Feb2018, Vol. 48 Issue 2, p228-229. 233p. 1 Chart.

Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.

Authors: Neef, Pieter A. Burrell, Louise M. McDonald, Christine F. et al.

Source: Internal Medicine Journal. Sep2017, Vol. 47 Issue 9, p1043-1050. 1094p.

Renal ACE2 (Angiotensin-Converting Enzyme 2) Expression Is Modulated by Dietary Fiber Intake, Gut Microbiota, and Their Metabolites.

Authors: Snelson, Matthew R. Muralitharan, Rikeish Dinakis, Evany et al.

Source: Hypertension (0194911X). Jun2021, Vol. 77 Issue 6, pe53-e55.

The ACE2 gene: its potential as a functional candidate for cardiovascular disease.

Authors: BURRELL, Louise M. HARRAP, Stephen B. VELKOSKA, Elena et al.

Source: Clinical Science. 2013, Vol. 124 Issue 2, p65-76. 12p.

This result is not displayed to guests.
Login for full access.

ACE2, a new regulator of the renin–angiotensin system

Authors: Burrell, Louise M. Johnston, Colin I. Tikellis, Christos et al.

Source: Trends in Endocrinology & Metabolism. May2004, Vol. 15 Issue 4, p166. 4p.

Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.

Authors: Cao, Zemin Burrell, Louise M. Tikkanen, Ilkka et al.

Source: Kidney International. Aug2001, Vol. 60 Issue 2, p715-721. 7p. 6 Black and White Photographs, 2 Charts, 3 Graphs.

Quality of Life and Function After TAVI in Adults Aged ≥90 Years: Frailty and Multimorbidity Matter.

Authors: Cameron, James N. Cailes, Benjamin Lancefield, Terase F. et al.

Source: Heart, Lung & Circulation. Jun2026, Vol. 35 Issue 6, p821-831. 11p.

Long-term effects of nonpeptide vasopressin V[sub 2] antagonist OPC-31260 in heart failure in the rat.

Authors: Burrell, Louise M. Phillips, Paddy A. Risvanis, John et al.

Source: American Journal of Physiology. Jul98 Part 2 of 2, Vol. 275 Issue 1, pH176. 7p. 4 Charts, 2 Graphs.